Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 50 of 508 for:    penis

Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) (PAZOPEN-SOGUG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02279576
Recruitment Status : Terminated (The low recruitment of patients will not allow to complete the study with the required number of patients within reasonable time.)
First Posted : October 31, 2014
Last Update Posted : October 14, 2016
Information provided by (Responsible Party):
Spanish Oncology Genito-Urinary Group

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 2016
Actual Study Completion Date : September 2016